Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Jennifer Diamond

Associate Professor

University of Colorado Anschutz Medical Campus

United States

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Pharmacotherapy

80%

Immunology

30%

Oncology

50%

Neoadjuvant Therapy

30%

Cancer Biology

30%

Targeted Therapy

30%

Antibody Therapy

30%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles10

Tackling metastatic triple-negative breast cancer with sacituzumab govitecan.

Article Link

Year:

2021

A Phase 1 Study of an MPS1 Inhibitor (BAY 1217389) in Combination with Paclitaxel using a novel Randomized Continual Reassessment Method for Dose Escalation.

Article Link

Year:

2021

Tumor-Specific Major Histocompatibility-II Expression Predicts Benefit to Anti-PD-1/L1 Therapy in Patients With HER2-Negative Primary Breast Cancer.

Article Link

Year:

2021

Moving Towards Targeted Therapies for Triple-Negative Breast Cancer.

Article Link

Year:

2021

Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer.

Article Link

Year:

2021

Sapanisertib Plus Exemestane or Fulvestrant in Women with Hormone Receptor-Positive/HER2-Negative Advanced or Metastatic Breast Cancer.

Article Link

Year:

2021

Clinical Outcomes for Patients With Metastatic Breast Cancer Treated With Immunotherapy Agents in Phase I Clinical Trials.

Article Link

Year:

2021

Testing Cancer Immunotherapy in a Human Immune System Mouse Model: Correlating Treatment Responses to Human Chimerism, Therapeutic Variables and Immune Cell Phenotypes.

Article Link

Year:

2021

WEE1 Inhibition in Combination With Targeted Agents and Standard Chemotherapy in Preclinical Models of Pancreatic Ductal Adenocarcinoma.

Article Link

Year:

2021

A phase I pharmacokinetic and safety study of Paclitaxel Injection Concentrate for Nano-dispersion (PICN) alone and in combination with carboplatin in patients with advanced solid malignancies and biliary tract cancers.

Article Link

Year:

2021

Collaborators3

Jing Wang

Professor

UNITED STATES

Morgan MacBeth

Senior Professional Research Assistant

University of Colorado Anschutz Medical Campus

UNITED STATES

Brian Freed

Professor of Medicine and Immunology

University of Colorado Anschutz Medical Campus

UNITED STATES

How do I reach out?

Meet Kite AI